Figure 2. The Cumulative Event‐Free Survival Analysis for Primary End Point According to Baseline LFSs.

(A) NFS; (B) FIB‐4; (C) BARD; (D) AST/ALT ratio; (E) Forns score; (F) GPR; (G) APRI; (H) HUI. ALT indicates alanine aminotransferase; APRI, AST to platelet ratio index; AST, aspartate aminotransferase; BARD, body mass index, AST/ALT ratio, diabetes mellitus score; FIB‐4, fibrosis‐4; GPR, gamma‐glutamyltransferase platelet ratio; and NFS, nonalcoholic fatty liver disease fibrosis score.